Steatocrit: what high and normal results mean

Published October 7, 2026 · Updated October 18, 2026 · 5 min read

Steatocrit is a stool test that estimates fecal fat as a percentage. On GI-MAP™, a high steatocrit result can raise a question about how well you digest or absorb fat. It cannot identify the cause, diagnose pancreatic insufficiency or tell you which treatment to take.

On this page

What is steatocrit?

The laboratory spins a prepared stool sample, then compares its fat layer with the liquid-free portion to calculate a percentage. Acid steatocrit uses acid during preparation to help separate fat. [1]

GI-MAP includes steatocrit among its intestinal-health markers. The laboratory describes a centrifugation method for this marker; the panel’s microbial qPCR DNA method does not measure the steatocrit result. Use the sample report to see where digestion markers appear. [2]

A percentage is not grams of fat lost per day

A spot steatocrit and a timed fecal-fat collection answer related questions using different procedures. A timed test collects stool over a specified period and may report fat loss in grams per day. You cannot directly convert your steatocrit percentage into that number—or into the percentage of your meals you failed to absorb.

A small 1997 study compared acid steatocrit with 72-hour fecal-fat testing in adults. That supports studying the method, but it does not establish the accuracy of today’s GI-MAP assay in every patient. It was not a GI-MAP validation study. [3]

What does high steatocrit mean?

A value flagged high suggests increased fecal fat in the sample. Possible explanations include pancreatic insufficiency, problems involving bile salts and small-intestinal disease such as celiac disease. A clinician needs other evidence to distinguish these causes. [1]

The result matters most alongside symptoms and health history. Persistent loose, greasy stools, weight loss, bloating or abdominal discomfort deserve clinical attention. NIDDK advises talking with a doctor about symptoms of pancreatic insufficiency because other digestive conditions can cause similar problems. [4]

What is the normal steatocrit range?

Use your report’s reference interval: methods and thresholds differ between laboratories. Age also matters, because infant values can be much higher and more variable. Another laboratory’s cutoff should not override your report. [1]

For example, a result of 18% cannot be interpreted responsibly without knowing the laboratory, method, reference interval and clinical context. The number alone does not tell you the cause or severity of a digestive condition.

Does a normal or low result rule out a problem?

A result within range means this sample was not flagged high by that laboratory. It does not assess every digestive function. A low number is not, by itself, a nutrient-deficiency diagnosis or a reason to try to raise steatocrit. Persistent symptoms still need assessment, even when this marker looks reassuring.

Steatocrit versus pancreatic elastase

  • Steatocrit: estimates fecal fat. An elevated value does not locate the problem in the pancreas.
  • Pancreatic elastase-1: measures a pancreatic enzyme in stool and helps evaluate exocrine pancreatic insufficiency (EPI).

The American Gastroenterological Association recommends fecal elastase on a solid or semi-solid specimen as the initial test when evaluating EPI. Values below 100 µg/g provide good evidence of EPI; 100–200 µg/g is indeterminate and needs further evaluation. These are elastase values, not steatocrit cutoffs. See the pancreatic elastase guide for the separate interpretation. [5]

High steatocrit with an elastase result in range does not automatically prove a bile problem. High steatocrit with low elastase does not determine an enzyme dose. The combination helps frame the clinical question; it does not replace a diagnosis.

Collection and next steps

Follow the instructions supplied with your kit and ordering clinician. Record relevant medicines, supplements and usual dietary intake. Preparation requirements for another laboratory’s steatocrit test or a formal 72-hour collection may differ; do not apply them to GI-MAP on your own.

AGA guidance notes that quantitative fecal-fat testing is rarely needed in routine EPI evaluation and requires specific dietary preparation. Ask whether another test would change your care before repeating a broad panel. [5]

Questions to bring to your appointment
  • Is the result high according to this laboratory’s interval?
  • Do my symptoms, weight changes or history suggest impaired fat digestion or absorption?
  • Does the elastase result help, and was the specimen suitable?
  • Would targeted testing or a nutrition assessment answer the remaining question?

Common questions

Is steatocrit the same as steatorrhea?

No. Steatocrit is a laboratory measurement. Steatorrhea means excess fat in stool. A stool’s appearance alone does not provide a steatocrit percentage. [1]

How do I lower high steatocrit?

The useful goal is to identify and manage any underlying problem, not chase a laboratory number. Do not start enzymes or sharply restrict dietary fat solely because steatocrit is high. AGA cautions that improvement during an enzyme trial is unreliable for diagnosing EPI. [5]

Does GI-MAP diagnose fat malabsorption or celiac disease?

The steatocrit result can contribute information about fecal fat, but the panel does not establish its cause. If celiac disease is a concern, ask about the appropriate clinical evaluation; stool anti-gliadin IgA is not a substitute for recommended celiac testing.

Sources and review

Sources checked October 18, 2026. Manufacturer material describes the assay; independent laboratory information, primary research and clinical guidance inform the interpretation limits.

  1. Canterbury Health Laboratories: Steatocrit, Faeces—method and laboratory-specific interpretation
  2. Diagnostic Solutions Laboratory: GI-MAP White Paper, steatocrit methodology (manufacturer source)
  3. Amann et al.: Acid steatocrit compared with fecal-fat methods, 1997
  4. NIDDK: Symptoms and causes of exocrine pancreatic insufficiency
  5. AGA Clinical Practice Update: Evaluation and management of exocrine pancreatic insufficiency, 2023

This article has been reviewed by Madison Ordway, FDN-P. For a correction or source question, contact Gi Map Test.